<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171210037809N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-08-04</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Poleium Teucrium supplementation ,exercise  and  chylomicron, HDL and KCL</public_title>
      <acronym></acronym>
      <scientific_title>The effects of   Poleium  Teucrium supplementation and a course selected exercise on chylomicron, HDL and KCL on  military men 20-25 years old</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>130</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40417</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Other, Randomization description: Names of male volunteer  who interested to cooperation Will be recorded /then they will complete the questionnaire of entry standard/ 20 persons will be selected  using a randomized table / then they will be numbered and their names will be written on sheets and will be spilled in a bowl.One sheet will be selected in tern and the names will be in one of the groups(2 groups of 10 people), Blinding description: None of the subjects know what substance they will consume.</study_design>
      <phase>N/A</phase>
      <hc_freetext>There is no illness / the effect of the toner is to be practiced.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Teucrium polium and exercise,The group 1 week before training  received 125 mg of   Teucrium polium  tropic extract every day.The Teucrium polium used by the Iranian Food and Drug Administration has been approved.  Teucrium polium  is the product of the plant distillation plant in Birjand. The main components of its chemical composition are alpha-pinene, linalool, chromophilium oxide, thermacrin D, beta-carophilin and delta-cadinen  / The protocol training  for this group will be 3 sessions per week for 8 weeks and each session will be 75-60 minutes. Intervention 2: Control group: exercise and placebo,The group 1 week before training received 125 mg of   Dextrose  soluble every day.The Dextrose used by the Iranian Food and Drug Administration has been approved.  Dextrose  is the product of the plant distillation plant in Birjand. The protocol training  for this group will be 3 sessions per week for 8 weeks and each session will be 75-60 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>ehsan roostaii</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>naghshe- jahan</address>
        <city>varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1637876791</zip>
        <telephone>+98 21 3672 5014</telephone>
        <email>dastavard96@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>ehsan roostaii</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>naghshe-jahan</address>
        <city>varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1637876791</zip>
        <telephone>+98 21 3672 5013</telephone>
        <email>dastavard96@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1.Over the past six months, they have not consumed any supplements or medications
It does not exclude any history of common chronic health problems and diseases, such as respiratory, metabolic, cardiovascular, renal and hepatic diseases</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>25 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Teucrium polium and exercise,The group 1 week before training  received 125 mg of   Teucrium polium  tropic extract every day.The Teucrium polium used by the Iranian Food and Drug Administration has been approved.  Teucrium polium  is the product of the plant distillation plant in Birjand. The main components of its chemical composition are alpha-pinene, linalool, chromophilium oxide, thermacrin D, beta-carophilin and delta-cadinen  / The protocol training  for this group will be 3 sessions per week for 8 weeks and each session will be 75-60 minutes.</i_keyword>
      <i_keyword>Control group: exercise and placebo,The group 1 week before training received 125 mg of   Dextrose  soluble every day.The Dextrose used by the Iranian Food and Drug Administration has been approved.  Dextrose  is the product of the plant distillation plant in Birjand. The protocol training  for this group will be 3 sessions per week for 8 weeks and each session will be 75-60 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Triglyceride. Timepoint: At the beginning of the study (before the intervention) and after 8 weeks of supplementation and exercise. Method of measurement: Blood collection :changes triglyceride : mg / dl.</prim_outcome>
      <prim_outcome>HDL. Timepoint: At the beginning of the study (before the intervention) and after 8 weeks. Method of measurement: Blood collection :changes HDL : mg / dl.</prim_outcome>
      <prim_outcome>LDL. Timepoint: At the beginning of the study (before the intervention) and after 8 weeks. Method of measurement: Blood collection :changes LDL : mg / dl.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-01-02</approval_date>
        <contact_name>Ethics Committee of the Faculty of Medical Sciences of Islamic Azad University, Varamin Prison</contact_name>
        <contact_address>naghshe- jahan/ IAU VARAMIN varamin/ pishva Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
